Serotonin gene polymorphisms and bipolar I disorder: Focus on the serotonin transporter

Annals of Medicine

Volumn 37, Issue 8, 2005, Pages 590-602

  Mansour, Hader A ^a   Talkowski, Michael E ^a   Wood, Joel ^a   Pless, Lora ^a   Bamne, Mikhil ^a   Chowdari, Kodavali V ^a   Allen, Michael ^b   Bowden, Charles L ^c   Calabrese, Joseph ^d   El Mallakh, Rif S ^e   Fagiolini, Andrea ^a   Faraone, Stephen V ^f   Fossey, Mark D ^g   Friedman, Edward S ^a   Gyulai, Laszlo ^h   Hauser, Peter ^i,j   Ketter, Terence A ^k   Loftis, Jennifer M ^i,j   Marangell, Lauren B ^l   Miklowitz, David J ^m   Nierenberg, Andrew A ⁿ   Patel, Jayendra ^o   Sachs, Gary S ⁿ   Sklar, Pamela ⁿ   Smoller, Jordan W ⁿ   Thase, Michael E ^a   Frank, Ellen ^a   Kupfer, David J ^a   Nimgaonkar, Vishwajit L ^p,q   more..

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e University of Louisville School of Medicine   (United States)

^f SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^g UNIVERSITY OF OKLAHOMA TULSA   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ PORTLAND VA MEDICAL CENTER   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m UNIVERSITY OF COLORADO   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^o UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^p UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^q WPIC   (United States)

more..

Author keywords

Association; Bipolar disorder; Genetic; Polymorphism; Serotonin; Serotonin transporter

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

BIPOLAR I DISORDER; BLOOD SAMPLING; DATA ANALYSIS; DISEASE ASSOCIATION; GENE DELETION; GENE INSERTION; GENE TARGETING; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MEDICAL LITERATURE; NEUROTRANSMISSION; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

BIPOLAR DISORDER; DNA; HUMANS; POLYMORPHISM, GENETIC; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 28844469295     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890500357428     Document Type: Review

References (108)

1. Gershon ES, Martinez M, Goldin LR, Gejman PV. Genetic mapping of common diseases: the challenges of manic-depressive illness and schizophrenia. Trends Genet. 1990;6:282-7.
2. Craddock N, Jones I. Genetics of bipolar disorder. J Med Genet. 1999;36:585-94.
3. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-7.
4. Veenstra-VanderWeele J, Anderson GM, Cook EH, Jr. Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol. 2000;410:165-81.
5. Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry. 1998;44:179-92.
6. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem. 1994;40:288-95.
7. Sibille E, Pavlides C, Benke D, Toth M. Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci. 2000;20:2758-65.
8. Gingrich JA, Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl). 2001;155:1-10.
9. Murphy DL, Uhl GR, Holmes A, Ren-Patterson R, Hall FS, Sora I, et al. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes Brain Behav. 2003;2:350-64.
10. Joyce PR, Mulder RT, Luty SE, McKenzie JM, Miller AL, Rogers GR, et al. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacology. 2003;6:339-46.
11. Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP. Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry. 2004;9:879-89.
12. Neumeister A, Young T, Stastny J. Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology (Berl). 2004;174:512-24. Epub. 2004 Jul 13.
13. Boularand S, Darmon MC, Ganem Y, Launay JM, Mallet J. Complete coding sequence of human tryptophan hydroxylase. Nucleic Acids Res. 1990;18:4257.
14. Craig SP, Boularand S, Darmon MC, Mallet J, Craig IW. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization. Cytogenet Cell Genet. 1991;56:157-9.
15. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76.
16. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science. 2004;305:217.
17. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, et al. Association Between the Tryptophan Hydroxylase Gene and Manic-depressive Illness. Arch Gen Psychiatry. 1998;55:33-7.
18. Vincent JB, Masellis M, Lawrence J, Choi V, Gurling HM, Parikh SV, et al. Genetic association analysis of serotonin system genes in bipolar affective disorder. Am J Psychiatry. 1999;156:136-8.
19. Rietschel M, Schorr A, Albus M, Franzek E, Kreiner R, Held T, et al. Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controls. Am J Med Genet. 2000;96:310-1.
20. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. Am J Med Genet. 1998;81:245-7.
21. Serretti A, Cristina S, Lilli R, Cusin C, Lattuada E, Lorenzi C, et al. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet. 2002;114:361-9.
22. Kirov G, Owen MJ, Jones I, McCandless F, Craddock N. Tryptophan hydroxylase gene and manic-depressive illness [letter; comment]. Arch Gen Psychiatry. 1999;56:98-9.
23. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Neuron. 2005;45:11-6.
24. De Luca V, Mueller DJ, Tharmalingam S, King N, Kennedy JL. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol Psychiatry. 2004;9:896-7.
25. Bonnier B, Gorwood P, Hamon M, Sarfati Y, Boni C, Hardy-Bayle MC. Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry. 2002;51:762-5.
26. Chee IS, Lee SW, Kim JL, Wang SK, Shin YO, Shin SC, et al. 5-HT2A receptor gene promoter polymorphism-1438A/G and bipolar disorder. Psychiatr Genet. 2001;11:111-4.
27. Mahieu B, Souery D, Lipp O, Mendelbaum K, Verheyen G, De Maertelaer V, et al. No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism. Psychiatry Res. 1997;70:65-9.
28. Gutierrez B, Bertranpetit J, Collier D, Arranz MJ, Valles V, Guillamat R, et al. Genetic variation of the 5-HT2A receptor gene and bipolar affective disorder. Hum Genet. 1997;100:582-4.
29. Massat I, Souery D, Lipp O, Blairy S, Papadimitriou G, Dikeos D, et al. A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorder. Am J Med Genet. 2000;96:136-40.
30. Tut TG, Wang JL, Lim CC. Negative association between T102C polymorphism at the 5-HT2A receptor gene and bipolar affective disorders in Singaporean Chinese. J Affect Disord. 2000;58:211-4.
31. Serretti A, Lattuada E, Catalano M, Smeraldi E. Serotonin transporter gene not associated with psychotic symptomatology of mood disorders. Psychiatry Res. 1999;86:59-65.
32. Blairy S, Massat I, Staner L, Le Bon O, Van Gestel S, Van Broeckhoven C, et al. 5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait. Am J Med Genet. 2000;96:360-4.
33. Murphy VE, Mynett-Johnson LA, Claffey E, Shields DC, McKeon P. No association between 5HT-2A and bipolar disorder irrespective of genomic imprinting. Am J Med Genet. 2001;105:422-5.
34. Ranade SS, Mansour H, Wood J, Chowdari KV, Brar LK, Kupfer DJ, et al. Linkage and association between serotonin 2A receptor gene polymorphisms and bipolar I disorder. Am J Med Genet. 2003;121B:28-34.
35. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet. 1995;57:455-64.
36. Milatovich A, Hsieh CL, Bonaminio G, Tecott L, Julius D, Francke U. Serotonin receptor Ic gene assigned to X chromosome in human (band q24) and mouse (bands D-F4). Hum Mol Genet. 1992;1:681-4.
37. Naughton M, Mulrooney JB, Leonard BE. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol. 2000;15:397-415.
38. Gutierrez B, Fananas L, Arranz MJ, Valles V, Guillamat R, van Os J, et al. Allelic association analysis of the 5-HT2C receptor gene in bipolar affective disorder. Neurosci Lett. 1996;212:65-7.
39. Oruc L, Verheyen GR, Furac I, Jakovljevic M, Ivezic S, Raeymaekers P, et al. Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder. Am J Med Genet. 1997;74(5):504-6.
40. Gutierrez B, Arias B, Papiol S, Rosa A, Fananas L. Association study between novel promoter variants at the 5-HT2C receptor gene and human patients with bipolar affective disorder. Neurosci Lett. 2001;309:135-7.
41. Meyer J, Saam W, Mossner R, Cangir O, Ortega GR, Tatschner T, et al. Evolutionary conserved microsatellites in the promoter region of the 5-hydroxytryptamine receptor 2C gene (HTR2C) are not associated with bipolar disorder in females. J Neural Transm. 2002;109:939-46.
42. Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S, et al. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry. 2001;6:579-85.
43. Serretti A, Lilli R, Lorenzi C, Lattuada E, Smeraldi E. Serotonin-2C and serotonin-1A receptor genes are not associated with psychotic symptomatology of mood disorders. Am J Med Genet. 2000;96:161-6.
44. Niesler B, Flohr T, Nothen MM, Fischer C, Rietschel M, Franzek E, et al. Association between the 5′ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics. 2001;11:471-5.
45. Ohtsuki T, Ishiguro H, Detera-Wadleigh SD, Toyota T, Shimizu H, Yamada K, et al. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees. Mol Psychiatry. 2002;7:954-61.
46. Weyler W, Hsu YP, Breakefield XO. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther. 1990;47:391-417.
47. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, Oxford: Oxford University Press; 1990.
48. Lan NC, Heinzmann C, Gal A, Klisak I, Orth U, Lai E, et al. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. Genomics. 1989;4:552-9.
49. Chen ZY, Powell JF, Hsu YP, Breakefield XO, Craig IW. Organization of the human monoamine oxidase genes and long-range physical mapping around them. Genomics. 1992;14:75-82.
50. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998;103:273-9.
51. Black GC, Chen ZY, Craig IW, Powell JF. Dinucleotide repeat polymorphism at the MAOA locus. Nucleic Acids Res. 1991;19:689.
52. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993;262:578-80.
53. Hinds HL, Hendriks RW, Craig IW, Chen ZY. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics. 1992;13:896-7.
54. Lim LC, Powell J, Sham P, Castle D, Hunt N, Murray R, et al. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. Am J Med Genet. 1995;60:325-31.
55. Kawada Y, Hattori M, Dai XY, Nanko S. Possible association between monoamine oxidase A gene and bipolar affective disorder. Am J Hum Genet. 1995;56:335-6.
56. Rubinsztein DC, Leggo J, Goodburn S, Walsh C, Jain S, Paykel ES. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum Mol Genet. 1996;5:779-82.
57. Preisig M, Bellivier F, Fenton BT, Baud P, Berney A, Courtet P, et al. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry. 2000;157:948-55.
58. Craddock N, Daniels J, Roberts E, Rees M, McGuffin P, Owen MJ. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. Am J Med Genet. 1995;60:322-4.
59. Muramatsu T, Matsushita S, Kanba S, Higuchi S, Manki H, Suzuki E, et al. Monoamine oxidase genes polymorphisms and mood disorder. Am J Med Genet. 1997;74:494-6.
60. Sasaki T, Hattori M, Sakai T, Kato T, Kunugi H, Hirose T, et al. The monoamine oxidase-A gene and major psychosis in Japanese subjects. Biol Psychiatry. 1998;44:922-4.
61. Syagailo YV, Stober G, GraBle M, Reimer E, Knapp M, Jungkunz G, et al. Association analysis of the functional monoamine oxidase a gene promoter polymorphism in psychiatric disorders. Am J Med Genet. 2001;105:168-171.
62. Nothen MM, Eggermann K, Albus M, Borrmann M, Rietschel M, Korner J, et al. Association analysis of the monoamine oxidase A gene in bipolar affective disorder by using family-based internal controls. Am J Hum Genet. 1995;57:975-8.
63. Parsian A, Todd RD. Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data. Am J Med Genet. 1997;74:475-9.
64. Kirov G, Norton N, Jones I, McCandless F, Craddock N, Owen MJ. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. Int J Neuropsychopharmcol. 1999;2:293-8.
65. Preisig M, Ferrero F, Malafosse A. Monoamine oxidase a and tryptophan hydroxylase gene polymorphisms: are they associated with bipolar disorder? Am J Pharmacogenomics. 2005;5:45-52.
66. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 1996;7:1675-9.
67. Craddock N, Rees M, Norton N, Feldman E, McGuffin P, Owen MJ. Association between bipolar disorder and the VNTR polymorphism in intron 2 of the human serotonin transporter gene (HSERT). Psychiatr Genet. 1996;6:147.
68. Coyle N, Jones I, Robertson E, Lendon C, Craddock N. Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis. Lancet. 2000;356:1490-1.
69. Bellivier F, Henry C, Szoke A, Schurhoff F, Nosten-Bertrand M, Feingold J, et al. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci Lett. 1998;255:143-6.
70. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, et al. Organization of the human serotonin transporter gene. J Neural Transm (General Sect). 1994;95:157-62.
71. Kirov G, Rees M, Jones I, MacCandless F, Owen MJ, Craddock N. Bipolar disorder and the serotonin transporter gene: a family-based association study. Psychol Med. 1999;29:1249-54.
72. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES, et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet. 1998;81:58-63.
73. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B (Neuropsychiatr Genet). 2005;133:110-5.
74. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. No association of serotonin transporter gene (SLC6A4) with schizophrenia and bipolar disorder in Japanese patients: association analysis based on linkage disequilibrium. J Neural Transm. 2005;5:5.
75. Mynett-Johnson L, Kealey C, Claffey E, Curtis D, Bouchier-Hayes L, Powell C, et al. Multimarker haplotypes within the serotonin transporter gene suggest evidence of an association with bipolar disorder. Am J Med Genet. 2000;96:845-9.
76. Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES, et al. Serotonin transporter (5-HTT) gene and bipolar affective disorder. Am J Med Genet. 1998;81:37-40.
77. Mundo E, Walker M, Tims H, Macciardi F, Kennedy JL. Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder. Am J Med Genet. 2000;96:379-83.
78. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry. 2000;5:32-8.
79. Jorde LB. Linkage disequilibrium as a gene-mapping tool. American Journal of Human Genetics. 1995;56:11-4.
80. Chowdari KV, Mimics K, Semwal P, Wood J, Lawrence E, Bhatia T, et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet. 2002;11:1373-80.
81. Nurnberger JI, Jr., Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry. 1994;51:849-59;discussion 863-4.
82. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003;53:1028-42.
83. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl. 20):22-33;quiz 34-57.
84. Spitzer R, Williams J, Gibbon M. Structured Clinical Interview for DSM-IV, Outpatient Version (SCID-OP). New York: Biometrics Research Department, New York State Psychiatric Institute; 1996.
85. Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N, et al. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry. 2002;7:278-88.
86. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66:2621-4.
87. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilties in linakge analysis. American Journal of Human Genetics. 1998;63:259-266.
88. Jorde LB. Linkage disequilibrium and the search for complex disease genes. Genome Res. 2000;10:1435-44.
89. Lewontin RC. On measures of gametic disequilibrium. Genetics. 1988;120:849-52.
90. Weiss KM, Clark AG. Linkage disequilibrium and the mapping of complex human traits. Trends Genet. 2002;18:19-24.
91. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-5, Epub. 2004 Aug 05.
92. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995;29:311-22.
93. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, Roeder K. Characterization of multilocus linkage disequilibrium. Genet Epidemiol. 2005;6:6.
94. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-247.
95. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 2003;25:115-21.
96. Devlin B, Roeder K. Genomic control for association studies. Biometrics. 1999;55:997-1004.
97. Ospina-Duque J, Duque C, Carvajal-Carmona L, Ortiz-Barrientos D, Soto I, Pineda N, et al. An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia. Neurosci Lett. 2000;292:199-202.
98. Mendlewicz J, Massat I, Souery D, Del-Favero J, Oruc L, Nothen MM, et al. Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur J Hum Genet. 2004;12:377-82. Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer.
99. Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D, et al. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am J Med Genet. 1998;81:1-3.
100. Ohara K, Nagai M, Tsukamoto T, Tani K, Suzuki Y. Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders. Biol Psychiatry. 1998;44:550-4.
101. Gutierrez B, Arranz MJ, Collier DA, Valles V, Guillamat R, Bertranpetit J, et al. Serotonin transporter gene and risk for bipolar affective disorder: an association study in Spanish population. Biol Psychiatry. 1998;43:843-7.
102. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet. 1995;59(Pt 3):323-36.
103. Sun F, Flanders WD, Yang Q, Khoury MJ. Transmission disequilibrium test (TDT) when only one parent is available: the 1-TDT. Am J Epidemiology. 1999;150:97-104.
104. Kunugi H, Tatsumi M, Sakai T, Hattori M, Nanko S. Serotonin transporter gene polymorphism and affective disorder [letter; comment]. Lancet. 1996;347:1340.
105. Bellivier F, Laplanche JL, Leboyer M, Feingold J, Bottos C, Allilaire JF, et al. Serotonin transporter gene and manic depressive illness: an association study. Biol Psychiatry. 1997;41:750-2.
106. Rees M, Norton N, Jones I, McCandless F, Scourfield J, Holmans P, et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry. 1997;2:398-402.
107. Oliveira JR, Carvalho DR, Pontual D, Gallindo RM, Sougey EB, Gentil V, et al. Analysis of the serotonin transporter polymorphism (5-HTTLPR) in Brazilian patients affected by dysthymia, major depression and bipolar disorder. Mol Psychiatry. 2000;5:348-9.
108. Saleem Q, Ganesh S, Vijaykumar M, Reddy YC, Brahmachari SK, Jain S. Association analysis of 5HT transporter gene in bipolar disorder in the Indian population. Am J Med Genet. 2000;96:170-2.